• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Non-conventional Inhibitory CD4Foxp3PD-1 T Cells as a Biomarker of Immune Checkpoint Blockade Activity.

作者信息

Zappasodi Roberta, Budhu Sadna, Hellmann Matthew D, Postow Michael A, Senbabaoglu Yasin, Manne Sasikanth, Gasmi Billel, Liu Cailian, Zhong Hong, Li Yanyun, Huang Alexander C, Hirschhorn-Cymerman Daniel, Panageas Katherine S, Wherry E John, Merghoub Taha, Wolchok Jedd D

出版信息

Cancer Cell. 2018 Oct 8;34(4):691. doi: 10.1016/j.ccell.2018.09.007.

DOI:10.1016/j.ccell.2018.09.007
PMID:30300585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6656529/
Abstract
摘要

相似文献

1
Non-conventional Inhibitory CD4Foxp3PD-1 T Cells as a Biomarker of Immune Checkpoint Blockade Activity.非传统抑制性CD4Foxp3PD-1 T细胞作为免疫检查点阻断活性的生物标志物
Cancer Cell. 2018 Oct 8;34(4):691. doi: 10.1016/j.ccell.2018.09.007.
2
Non-conventional Inhibitory CD4Foxp3PD-1 T Cells as a Biomarker of Immune Checkpoint Blockade Activity.非常规抑制性 CD4Foxp3PD-1 T 细胞作为免疫检查点阻断活性的生物标志物。
Cancer Cell. 2018 Jun 11;33(6):1017-1032.e7. doi: 10.1016/j.ccell.2018.05.009.
3
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
4
Efficacy of PD-1 blockade in cervical cancer is related to a CD8FoxP3CD25 T-cell subset with operational effector functions despite high immune checkpoint levels.尽管免疫检查点水平较高，但 PD-1 阻断在宫颈癌中的疗效与具有操作效应功能的 CD8FoxP3CD25T 细胞亚群有关。
J Immunother Cancer. 2019 Feb 12;7(1):43. doi: 10.1186/s40425-019-0526-z.
5
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4Foxp3 Cell-Mediated Modulation of CD103 Dendritic Cells.双重 PD-1 和 CTLA-4 检查点阻断通过 CD4Foxp3 细胞介导的 CD103 树突状细胞调节促进抗肿瘤免疫反应。
Cancer Immunol Res. 2018 Sep;6(9):1069-1081. doi: 10.1158/2326-6066.CIR-18-0291. Epub 2018 Jul 17.
6
Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer.双重 CTLA-4 和 PD-L1 阻断抑制结直肠癌高度侵袭性原位模型中的肿瘤生长和肝转移。
Neoplasia. 2019 Sep;21(9):932-944. doi: 10.1016/j.neo.2019.07.006. Epub 2019 Aug 11.
7
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.下一代免疫检查点抑制剂：黑色素瘤中的PD-1/PD-L1阻断
Clin Ther. 2015 Apr 1;37(4):764-82. doi: 10.1016/j.clinthera.2015.02.018. Epub 2015 Mar 29.
8
Restricting Glutamine or Glutamine-Dependent Purine and Pyrimidine Syntheses Promotes Human T Cells with High FOXP3 Expression and Regulatory Properties.限制谷氨酰胺或谷氨酰胺依赖性嘌呤和嘧啶合成可促进具有高FOXP3表达和调节特性的人T细胞。
J Immunol. 2016 May 1;196(9):3618-30. doi: 10.4049/jimmunol.1501756. Epub 2016 Mar 28.
9
High circulating CD4CD25FOXP3 T-cell sub-population early after lung transplantation is associated with development of bronchiolitis obliterans syndrome.高循环 CD4CD25FOXP3 T 细胞亚群在肺移植后早期与闭塞性细支气管炎综合征的发生有关。
J Heart Lung Transplant. 2018 Jun;37(6):770-781. doi: 10.1016/j.healun.2018.01.1306. Epub 2018 Mar 20.
10
Immune Checkpoint Blockade in Breast Cancer Therapy.免疫检查点阻断在乳腺癌治疗中的应用。
Adv Exp Med Biol. 2017;1026:383-402. doi: 10.1007/978-981-10-6020-5_18.

引用本文的文献

1
7aaRGD - a novel SPP1/integrin signaling-blocking peptide reverses immunosuppression and improves anti-PD-1 immunotherapy outcomes in experimental gliomas.7aaRGD——一种新型的SPP1/整合素信号阻断肽可逆转免疫抑制并改善实验性胶质瘤中抗PD-1免疫治疗的效果。
J Exp Clin Cancer Res. 2025 Apr 25;44(1):132. doi: 10.1186/s13046-025-03393-9.
2
Cytokine Storm Related to CD4 T Cells in Influenza Virus-Associated Acute Necrotizing Encephalopathy.流感病毒相关急性坏死性脑病中与CD4 T细胞相关的细胞因子风暴
Immune Netw. 2024 Apr 29;24(2):e18. doi: 10.4110/in.2024.24.e18. eCollection 2024 Apr.
3
Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry.多色谱流式细胞术动态评估 NSCLC 免疫检查点抑制剂反应的血液免疫细胞。
Front Immunol. 2023 Aug 10;14:1206631. doi: 10.3389/fimmu.2023.1206631. eCollection 2023.
4
Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies.非小细胞肺癌的免疫治疗抵抗：从机制到临床策略。
Front Immunol. 2023 Apr 6;14:1129465. doi: 10.3389/fimmu.2023.1129465. eCollection 2023.
5
Functional and molecular characterization of PD1 tumor-infiltrating lymphocytes from lung cancer patients.从肺癌患者肿瘤浸润淋巴细胞中鉴定 PD1 的功能和分子特征。
Oncoimmunology. 2022 Feb 9;11(1):2019466. doi: 10.1080/2162402X.2021.2019466. eCollection 2022.
6
Immune Microenvironment and Response in Prostate Cancer Using Large Population Cohorts.利用大型人群队列研究前列腺癌的免疫微环境和反应。
Front Immunol. 2021 Oct 28;12:686809. doi: 10.3389/fimmu.2021.686809. eCollection 2021.
7
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade.外周血细胞上LAG-3的表达可识别免疫检查点阻断后预后较差的患者。
Sci Transl Med. 2021 Aug 25;13(608). doi: 10.1126/scitranslmed.abf5107.
8
Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade.免疫检查点阻断预测生物标志物的进展与挑战
Front Oncol. 2021 Mar 11;11:617335. doi: 10.3389/fonc.2021.617335. eCollection 2021.
9
Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity.PD-1 和 CTLA-4 阻断治疗反应和耐药的新兴动力学途径：通过应对复杂性来解决不确定性。
J Exp Clin Cancer Res. 2021 Feb 18;40(1):74. doi: 10.1186/s13046-021-01872-3.
10
Obesity diminishes response to PD-1-based immunotherapies in renal cancer.肥胖降低了肾癌对 PD-1 为基础的免疫疗法的反应。
J Immunother Cancer. 2020 Dec;8(2). doi: 10.1136/jitc-2020-000725.